Fecal incontinence is defined as an involuntary loss of gas or liquid or solid stool. It includes not being able to hold in a bowel movement until reaching a toilet. You may also hear this referred to ...

Urinary and bowel disorders, manifesting as symptoms like frequent urination or difficulty in bowel movements, can greatly impact one's quality of life, even though they are not outwardly visible.

PHILADELPHIA -- Two-thirds of patients with fecal incontinence associated with loose stool experienced an improvement in symptoms when following a low FODMAP diet, a researcher reported here. "Fecal ...

An innovative experimental treatment for fecal incontinenceis showing results. "Nobody should have to struggle with what I'm struggling with, what I've been struggling with when there's this option," ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Older women who ...

Passive incontinence – refers to the involuntary discharge of stool or gas without awareness; Urge incontinence – refers to the discharge of fecal matter in spite of active attempts to retain bowel ...

The FDA has expanded the use of Renovia’s digital training approach to treating incontinence among women, greenlighting the program as a first-line, home-based option for people with chronic fecal ...

Welcome to Bathroom Break, Refinery29’s series all about poo and the complicated relationship we have with our bowels. To see the rest of the articles, click here. Soiling yourself – officially known ...

Fecal incontinence is a common problem for which patients may be reluctant to seek treatment, and there has been little evidence to support any medical or surgical interventions. Local injections to ...

The internal anal sphincter consists of smooth muscle and maintains 70% of the resting anal tone. The external anal sphincter consists of striated muscle and accounts for the remaining 30% of resting ...

Relationship between ERCC1 C8092A and Mad1 G558A polymorphism with disease progression, and survival in patients with advanced epithelial ovarian cancer treated with induction chemotherapy with ...